Topic: lobbying

EpiPen box

Mylan masterminds lobbying effort to escape EpiPen outcry: NYT

Mylan saw EpiPen pricing trouble coming months ago. So the company stepped up lobbying for EpiPen's move onto an official list of preventive meds that payers must provide for free. The upshot, if Mylan succeeds? Better patient access, but less pressure on its price hikes.